Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Price History
|
Ratios
|
Insiders
Bullboard - Stock Discussion Forum
Veru Inc
VERU
Healthcare
Biotechnology
Veru Inc., a late clinical stage biopharmaceutical company, focuses on developing medicines for treatment of metabolic diseases, oncology, and viral-induced acute respiratory distress syndrome (ARDS) in Florida and internationally. It provides FC2 female condom for the dual protection against unplanned pregnancy and the transmission of sexually transmitted infections. The company develops...
enobosarm, a selective androgen receptor modulator for treatment of augment fat loss and to prevent muscle loss in sarcopenic obese and overweight elderly patients; Enobosarm, an oral selective androgen receptor modulator for the treatment of AR+ ER+ HER2- metastatic breast cancer; and sabizabulin, a microtubule disruptor for the treatment of hospitalized patients with viral lung infection at high risk for viral induced ARDS and death. The company was formerly known as The Female Health Company and changed its name to Veru Inc. in July 2017. Veru Inc. was incorporated in 1971 and is headquartered i...
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Bullboard (NDAQ:VERU)
New Post
View:
Posts & Comments
Threaded Posts
(41)
•••
speedyg999
X
Post by
speedyg999
on Jul 11, 2022 5:55pm
Oppenheimer has US$36 Target for VERU
Up Up and Away. Poor Shorts. You almost have to feel sorry for them!
(4)
•••
AviseAnalytics
X
Post by
AviseAnalytics
on Jul 08, 2022 8:02am
HERE’S A ROUND-UP ON VERU INC!
$VERU Veru, Inc. (NASDAQ: VERU) announced positive results from a Phase 3 study evaluating the safety and efficacy of oral sabizabulin for the treatment of hospitalized moderate-severe
...more
(41)
•••
speedyg999
X
Post by
speedyg999
on Jul 06, 2022 6:14pm
SHORT SQUEEZE STARTING IN VERU
Watch this action, folks. There are a LOT of short sellers in this stock, and they are now losing their butts. if the FDA approves their Covid drug, this could double in short order. We should hear
...more
(657)
•••
Iseneschal
X
Post by
Iseneschal
on Apr 14, 2022 10:30am
VERU .....sold to America !!!!
Profit is almost $3.00 / share Cheers !
(657)
•••
Iseneschal
X
Post by
Iseneschal
on Apr 14, 2022 10:26am
VERU ..... Yeehaaaaaaaaa !!!!!
I f'ing told ya ........ What's it at now !!!!!! Halted again..... It could triple from $17....hang in there Baby !!! Cheers to me !!!!!!!!!!!!!!!!!!!!!!!!!!
(657)
•••
Iseneschal
X
Post by
Iseneschal
on Apr 14, 2022 10:15am
VERU ..... $14.50 now ; )
$17 dolla holla Cheers !
(657)
•••
Iseneschal
X
Post by
Iseneschal
on Apr 14, 2022 10:02am
VERU ...resumed ....dipped ...now on up swing
This could explode higher.... JMHO $14 now
(657)
•••
Iseneschal
X
Post by
Iseneschal
on Apr 14, 2022 9:44am
VERU ....halted and on Watch list
Cheers !
(4)
•••
AviseAnalytics
X
Post by
AviseAnalytics
on Aug 26, 2021 7:19am
3 BIOTECH STOCKS INSIDERS ARE SELLING
3 BIOTECH STOCKS INSIDERS ARE SELLING $VERU $FBIO $SGMO Learn More https://www.aviseanalytics.com/3-biotech-stocks-insiders-are-selling/
(24)
•••
TheMoneyMind
X
Post by
TheMoneyMind
on Dec 15, 2020 8:00am
VERU update
Still moving premarket tuesday! https://youtu.be/T8vPUhRoM2s
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
{{previousButtonTitle}}
{{nextButtonTitle}}
A daily snapshot of everything
from market open to close.
Podcasts